INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

20,939 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
23
Sylebra Capital LlcDirector
PIIMPINJ INC
Open-market sale
SELL$1.03M
7,163 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

Page 258 of 524
← PrevNext →
23
Sylebra Capital LlcDirector
PIIMPINJ INC
Open-market sale
SELL
$7.31M
48.5K sh
May 29, 2026
Jun 2, 2026
traded May 29, 2026
+4d
SEC Form 4

Evidence

22
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$1.54M
16.9K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

21
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$4.10M
60.0K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

21
BA
Bruggeworth Robert ADirector, President and CEO
QRVOQorvo, Inc.
Open-market sale · 10b5-1 plan
SELL$333K
3,251 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

21
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$2.66M
38.2K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

21
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$2.76M
40.0K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

21
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$2.66M
38.2K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

21
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$4.10M
60.0K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

21
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$2.76M
40.0K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

21
XC
Xu Cong ClaireSVP, Clinical Development
NBPNovaBridge Biosciences
Open-market sale
SELL$14K
3,494 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

20
AW
Allison John W IIDirector
HOMBHOME BANCSHARES INC
Open-market sale
SELL$53K
2,000 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

19
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$279K
1,216 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

19
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$324K
1,432 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

19
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$380K
4,159 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

17
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$1.71M
25.2K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

17
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$1.71M
25.2K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

16
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$133K
584 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

16
YM
Yi Boyer Jennifer MEVP Entrprs Enblmnt, Ch HR Off
INGNInogen Inc
Open-market sale · 10b5-1 plan
SELL$70K
10.8K sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

16
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$91K
400 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

16
PJ
Petley Richard JChief Revenue Officer
TDCTERADATA CORP /DE/
Open-market sale · 10b5-1 plan
SELL$568K
16.2K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

16
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$110K
491 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

16
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$152K
677 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

15
FH
Fiore Michael HenryEVP, CHIEF COMMERCIAL OFFICER
HQYHEALTHEQUITY, INC.
Open-market sale · 10b5-1 plan
SELL$298K
3,142 sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

14
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$819K
12.6K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

14
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$489K
7,400 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

14
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$995K
14.8K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

14
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$995K
14.8K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

14
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$198K
7,500 sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

14
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$819K
12.6K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

14
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$489K
7,400 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

13
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$46K
200 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

11
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$127K
1,800 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

11
HT
Hamilton Brian TDirector, President of CCBX
CCBCOASTAL FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$500K
7,000 sh
Jun 2, 2026Jun 2, 2026
traded Jun 2, 2026
+0dSEC Form 4

Evidence

11
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$127K
1,800 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

11
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$487K
5,428 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

8
SG
Steele Richard GSVP - General Counsel
MCOMOODYS CORP /DE/
Open-market sale · 10b5-1 plan
SELL$72K
158 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

6
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$121
34 sh
Jun 2, 2026Jun 2, 2026
traded Jun 2, 2026
+0dSEC Form 4

Evidence

6
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$710
200 sh
Jun 2, 2026Jun 2, 2026
traded Jun 2, 2026
+0dSEC Form 4

Evidence

6
PJ
Petley Richard JChief Revenue Officer
TDCTERADATA CORP /DE/
Open-market sale · 10b5-1 plan
SELL$35K
990 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence